 |
|
|
Daniel Bausch, MD
Associate Professor
Department of Tropical Medicine
Tulane University School of Public Health and Tropical Medicine
1440 Canal Street
New Orleans, LA 70112
Phone: (504) 988-6368
Fax: (504) 988-6686
dbausch@tulane.edu
|
Personal Statement:
Daniel Bausch, MD, MPH&TM, is an Associate Professor in the Department of Tropical Medicine and Section of Infectious Diseases, Department of Internal Medicine, at the Tulane University Health Sciences Center. He is board-certified in internal medicine and infectious diseases with a Masters of Public Health degree in tropical medicine. Although still actively participating in teaching and other scholarly activities at Tulane, Dr. Bausch is presently seconded to the U.S. Naval Medical Research Unit 6 in Lima, Peru, where he is the Director of the Emerging Infections Department. He specializes in the research and control of emerging tropical viruses. Formerly with the CDC Special Pathogens Branch, Dr. Bausch has extensive experience in sub-Saharan Africa, Latin America, and Asia combating pathogens such as Ebola and Lassa viruses, hantavirus, and SARS coronavirus. He serves as a frequent consultant for the World Health Organization, United Nations, and National Institutes of Health. Dr. Bausch places a strong emphasis on capacity building in all his projects and also has a keen interest in the role of the scientist in promoting health and human rights.
Research Interests:
Epidemiology and control of viral hemorrhagic fevers and emerging pathogens; building research capacity in developing countries; health and human rights
Educational Background:
- MPH&TM, Tulane University, New Orleans, Louisiana
- MD, Loyola Stritch School of Medicine, Maywood, Illionis
- BA, Northwestern University, Evanston, Illionis
Professional Achievements:
- 1988 Alpha Omega Alpha Medical Honor Society
- 1992 Board certified, internal medicine
- 1994 Valedictorian, Tulane School of Public Health and Tropical Medicine
- 1994 Delta Omega Public Health Honor Society
- 1995-present Founding member and board member, Doctors for Global Health
- 1995 Travel award, American Society of Tropical Medicine and Hygiene
- 1996 Board certified, infectious diseases
- 1996-2002 Director, CDC Lassa Fever Research Field Station, Guinea, West Africa
- 2001-2003 Commander, Public Health Service Commissioned Corps
- 2002 Secretary's Award for Distinguished Service, Uganda Ebola Outbreak Response Team, DHHS
- 2002, 2003 Foreign duty service awards, Public Health Service
- 2004-present Fellow, Center for Evidence-Based Global Health, Tulane School of Public Health and Tropical Medicine
- 2004-present Senior medical-technical coordinator, WHO Mano River Union Lassa Fever Network
- 2004 Secretary's Award for Distinguished Service, SARS Outbreak Response Team (Vietnam), DHHS
Selected Publications:
Bond N, Schieffelin JS, Moses LM, Bennett AJ, Bausch DG. A Historical Look at the First Reported Cases of Lassa Fever: IgG Antibodies 40 Years After Acute Infection. Am J Trop Med Hyg. 2012 Dec 31.
MacNeil A, Abel J, Reynolds MG, Lash RR, Fonnie R, Kanneh LD, Robert W, Lungay VK, Goba A, Moses LM, Damon IK, Karem K, and DG Bausch. Serologic evidence of human orthopoxvirus infections in
Sierra Leone. BMC Research Notes. In press.
Bausch DG. Ebola Virus as a Foodborne Pathogen? Cause for Consideration, but Not Panic. J Infect Dis. 2011 May 12; J Infect Dis. 2011 Jul;204(2):179-81.
Hadi CM, Goba A, Khan SH, Bangura J, Sankoh M, Koroma S, Juana B, Bah A, Coulibaly M, Bausch DG (2010). Ribavirin for lassa Fever postexposure prophy laxis. Emerg Infect Dis. 2010 Dec;16(12):2009-11.
Jentes ES, Robinson J, Johnson BW, Conde I, Sakouvougui Y, Iverson J, Beecher S, Bah MA, Diakite F, Coulibaly M, Bausch DG. (2010) Acute arboviral infections in Guinea, west Africa, 2006. Am J Trop Med Hyg 83(2):388-94.
Nnedu ON, Rimel B, Terry C, Jalloh-Vos H, Baryon B, and Bausch DG (2010). Syndromic diagnosis of malaria in rural Sierra Leone and proposed additions to the national integrated management of childhood illness guidelines for fever. Am J Trop Med Hyg 82(4):525-528.
Dery M and DG Bausch (2008). A DNA vaccine for the prevention of Ebola virus infection. Curr Opin Mol Ther 10(3):285-93.
Bausch DG, Sprecher AG, Jeffs B, and P Boumandouki (2008). Treatment of Marburg and Ebola hemorrhagic fevers: a strategy for testing new drugs and vaccines under outbreak conditions. Antiviral Res 78 (1):150-61.
Khan SH, Goba A, Chu M, Roth C, Healing T, Marx A, Fair J, Guttieri MC, Ferro P, Imes T, Monagin C, Garry RF, and DG Bausch for the Mano River Union Lassa Fever Network (2008). New opportunities for field research on the pathogenesis and treatment of Lassa fever. Antiviral Res 78 (1):103-115.
Swanepoel R, Smit SB, Rollin PE, Formenty P, Leman PA, Kemp A, Burt FJ, Grobbelaar AA, Croft J, Bausch DG, Zeller H, Leirs H, Braack LEO, Libande ML, Zaki S, Nichol ST, Ksiazek TG, and JT Paweska on behalf of the International Scientific and Technical Committee for Marburg Hemorrhagic Fever Control in the Democratic Republic of the Congo (2007). Studies of reservoir hosts for Marburg virus. Emerg Infect Dis 12:1847-51.
Bausch DG, Towner JS, Dowell SF, Kaducu F, Lukwiya M, Sanchez A, Nichol ST, Ksiazek TG, and PE Rollin (2007). Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis 196(Suppl 2):S142-7.
Bausch DG, Feldmann H, Geisbert TW, Bray M, Sprecher AG, Boumandouki P, Rollin PE, Roth C, and the Winnipeg Filovirus Clinical Working Group (2007). Outbreaks of filovirus hemorrhagic fever: Time to refocus on the patient. J Infect Dis 196(Suppl 2):S136-41
PE Rollin, Bausch DG, and A Sanchez (2007). Blood chemistry measurements and D-dimer levels associated with fatal and nonfatal outcomes in humans infected with Sudan Ebola virus. J Infect Dis 196(Suppl 2):S364-71.
Colebunders R, Tshomba A, Van Kerkhove MD, Bausch DG, Campbell P, Libande M, Pirard P, Tshioko F, Mardel S, Mulangu S, Sleurs H, Rollin PE, Muyembe-Tamfum JJ, Jeffs B, and M Borchert on behalf of the International Scientific and Technical Committee DRC Watsa/Durba 1999 Marburg Outbreak Investigation Group (2007). Marburg hemorrhagic fever in Durba and Watsa, Democratic Republic of the Congo: Clinical documentation, features of illness, and treatment. J Infect Dis 196(Suppl 2):S148-53
Fair J, Jentes E, Inapogui A, Kourouma K, Goba A, Bah A, Tounkara M, Coulibaly M, Garry RF, and DG Bausch (2007). Lassa virus-infected rodents in refugee camps in Guinea: a looming threat to public health in a politically unstable region. Vector Borne Zoonotic Dis 7(2):167-72
Bausch DG and TW Geisbert (2007). Development of vaccines for Marburg hemorrhagic fever. Expert Rev Vaccines 6(1):57-74
Bausch DG, Nichol ST, Muyembe-Tamfum JJ, Borchert M, Rollin PE, Sleurs H, Campbell P, Tshioko FK, Roth C, Colebunders R, Pirard P, Mardel S, Olinda LA, Zeller H, Tshomba A, Kulidri A, Libande ML, Mulangu S, Formenty P, Grein T, Leirs H, Braack L, Ksiazek T, Zaki S, Bowen MD, Smit SB, Leman PA, Burt FJ, Kemp A, and R Swanepoel for the International Scientific and Technical Committee for Marburg Hemorrhagic Fever Control in the Democratic Republic of the Congo (2006). Marburg hemorrhagic fever associated with multiple genetic lineages of virus. N Engl J Med. 355(9):909-919
Reynolds MG, Anh BH, Thu V, Montgomery JM, Bausch DG, Shah JJ, Maloney S, Leitmeyer KC, Horby P, Plant AJ, and TM Uyeki (2006). Factors associated with nosocomial SARS-CoV transmission among health care workers in Hanoi, Vietnam, 2003. BMC Public Health 6(1):207
Bausch DG (2005). Marburg and Ebola viruses. PIER: The Physicians' Information and Education Resource. American College of Physicians, electronic publication: http://pier.acponline.org/physicians/diseases/d891/d891.html (accessed August 30, 2006)
Nkoghe D, Formenty P, Leroy ÉM, Nnegue S, Obame Edou SY, Iba Ba J, Allarangar Y, Cabore J, Bachy C, Andraghetti R, de Benoist AC, Galanis E, Rose A, Bausch D, Reynolds M, Rollin P, Corera, Shongo R, Gergonne B, Koné LM, Yada A, Roth C and M Toung Mve (2005). Multiple Ebola virus haemorrhagic fever outbreaks in Gabon, from October 2001 to April 2002 [French, English abstract]. Bull Soc Pathol Exot, 98(3):224-229
Carroll DS, Mills JN, Montgomery JM, Bausch DG, Blair PJ, Burans JP, Felices V, Gianella A, Iihoshi N, Nichol ST, Olson JG, Rogers DS, Salazar M, and TG Ksiazek (2005). Hantavirus pulmonary syndrome in central Bolivia: relationships between reservoir hosts, habitats, and viral genotypes. American Journal of Tropical Medicine and Hygiene 72(1):54-58
Sanchez A, Lukwiya M, Bausch D, Mahanty S, Sanchez AJ, Wagoner KD, and PE Rollin (2004). Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitric oxide levels. J Virol 78(19):10370-10377
Towner JS, Rollin PE, Bausch DG, Sanchez A, Crary SM, Vincent M, Lee WF, Spiropoulou CF, Ksiazek TG, Lukwiya M, Kaducu F, Downing R, and ST Nichol (2004). Rapid Diagnosis of Ebola Hemorrhagic Fever by Reverse Transcription-PCR in an Outbreak Setting and Assessment of Patient Viral Load as a Predictor of Outcome. J Virol 78(8):4330–4341
Bausch DG and PE Rollin. Responding to Epidemics of Ebola Hemorrhagic Fever: Progress and Lessons Learned from Recent Outbreaks in Uganda, Gabon, and Congo. In Scheld WM, Murray BE, and JM Hughes (eds): Emerging Infections 6. Washington, D.C., ASM Press, 2004, pp 35-58
Bausch DG, Borchert M, Grein T, Roth C, Swanepoel R, Libande ML, Talarmin A, Bertherat E, Muyembe-Tamfum JJ, Tugume B, Colebunders R, Kondé KM, Pirard P, Olinda LL, Rodier GR, Campbell P, Tomori O, Ksiazek TG and PE Rollin (2003). Risk Factors for Marburg Hemorrhagic Fever in Durba and Watsa, Democratic Republic of the Congo. Emerg Infect Dis 9(12):1531-1537
Bausch DG, Demby AH, Coulibaly M, Kanu J, Goba A, Bah A, Condé N, Wurtzig HL, Cavallaro KF, Lloyd E, Baldet FB, Cissé SD, Fofonah D, Savané IK, Tolno RT, Mahy B, Wagoner KD, Ksiazek TG, Peters CJ and PE Rollin (2001). Lassa Fever in Guinea. I. Epidemiology of Human Disease and Clinical Observations. Vector Borne and Zoonotic Diseases 1(4):269-281
Demby AH, Inapougui A, Kargbo K, Koninga J, Kourouma K, Kanu J, Coulibaly M, Wagoner KD, Ksiazek TG, Peters CJ, Rollin PE and Bausch DG (2001). Lassa Fever in Guinea. II: Distribution and Prevalence of Lassa Virus Infection in Small Mammals. Vector Borne and Zoonotic Diseases 1(4):283-297
Bausch DG (2001) The Ebola virus…and the challenges to health research in Africa. United Nations Chronicle 38(2):6-13 (http://www.un.org/Pubs/chronicle/2001/issue2/0102p6.htm)
Mahanty S, Bausch DG, Thomas RL, Goba A, Bah A, Peters CJ and PE Rollin (2001). Low Levels of Interleukin-8 and Interferon-Inducible Protein-10 in Serum are Associated with Fatal Infections in Acute Lassa Fever. Journal of Infectious Diseases 183(12):1713-1721
Bausch DG, Rollin PE, Demby AH, Coulibaly M, Kanu J, Conteh AS, Wagoner KD, McMullan LK, Bowen MD, Peters CJ and TG Ksiazek (2000). Diagnosis and Clinical Virology of Lassa Fever as Evaluated by Enzyme-Linked Immunosorbent Assay, Indirect Fluorescent-Antibody Test, and Virus Isolation. Journal of Clinical Microbiology 38(7):2670-2677
Bausch D (1992) From the Trenches: Health Care in El Salvador. Links Health and Development Report 9(3):19-20
Level of Instruction:
graduate
[View all Tropical Medicine faculty]
